CYP 6.38% 25.0¢ cynata therapeutics limited

Ann: Final Preclinical Asthma Study Confirms Efficacy, page-12

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,848 Posts.
    lightbulb Created with Sketch. 218
    Should be good news.

    I am not sure to what extent asthma in humans is immune or auto-immune associated.

    I recall reading (re GVHD and T reg cells action) that human complement (involved in immunity) does not occur in mice and that they cannot even find a homolog.

    Good news is still good news but a mouse model pre-clinical success is a long way short of clinical success in humans.
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.